#Assays
How can molecular diagnostics improve detection of invasive fungal disease? Join us for a webinar on Oct. 6 that will compare targeted PCR assays and metagenomic sequencing and discuss their clinical utility, limitations, and integration into practice.

Register: https://ow.ly/pQRG50ZPJ1b
September 29, 2026 at 2:01 PM
🧬 UpTCR predicts TCR–antigen–HLA recognition from incomplete data. Eight predicted melanoma-antigen variants activated engineered Jurkat cells in lab assays. A tool for testing immune recognition—not a proven therapy.
doi.org/10.1038/s414...
#Immunology #AI
UpTCR: a unified progressive knowledge transfer foundation model for robust T-cell receptor-antigen binding recognition - Nature Communications
Peptides are presented to T Cell receptors (TCR) in the context of human leukocyte antigen (HLA) MHC molecules and the prediction of these peptide sequences are important for vaccines and cancer thera...
doi.org
September 29, 2026 at 1:48 PM
September 29, 2026 at 1:05 PM
Lab-validated qPCR assays for Mpox, SARS-CoV-2, M. tuberculosis, and C. albicans matched or exceeded CDC reference assay sensitivity.
September 29, 2026 at 10:03 AM
Jingwen Fan, et al.: Integration of functional immunomonitoring assays with PET/CT scans in TB patients identifies on-treatment biomarkers https://pasteur.hal.science/pasteur-05764964v1 [sdv]
September 29, 2026 at 3:00 AM
🚀 Northmin Hits 12.85% Copper and 933 g/t Silver in Highest Grade Tynagh Assays Yet
🔎 Read the full update:
➡️https://theminingnews.com/northmin-hits-12-85-copper-and-933-g-t-silver-in-highest-grade-tynagh-assays-yet/
#Northmin
#NorthminV#NMBn#TSXVI#Tynagh##IrelandS#CopperA#SilverD#Assays #Drilling
September 28, 2026 at 10:32 PM
Automate forbidden assays
September 28, 2026 at 7:00 PM
Drop by booth 228 at #HUPO2026 to explore a virtual model of the Nautilus Voyager™ Platform and discover how you can incorporate our AKT1 or EGFR proteoforms assays in your research free of charge through the Iterative Mapping Grant Program:

www.nautilus.bio/iterative-ma...
Iterative Mapping Grant Program ~ Nautilus Biotechnology
www.nautilus.bio
September 28, 2026 at 5:23 PM
Meet Eleanor, Inside Sales Account Manager at Proteintech.

Her PhD, why she left the bench, and her advice for a move into industry. Swipe through 👉

#TeamProteintech #ScienceCareers
September 28, 2026 at 5:14 PM
Validation work using cell-based assays and more sims followed. My personal highlight was the fact that the Russell group were able to design a ligand library that used substituents with different van der Waals radii to exploit the L336 lever as a way to modify bias. Check out the level of control!
September 28, 2026 at 4:32 PM
Attending SPAOM 2026?
Don't miss our workshop "What Are Endpoint Assays Missing? Label-Free Phenotyping of Live-Cell Responses" on Thursday 8th October at 12:45.

Until then, learn more about Nanolive's live cell imaging and analysis solutions in our brochure: x.sfmsg.co/aPohee75k
September 28, 2026 at 2:00 PM
And here's a nice résumé of our @natcomms.nature.com paper for the grand public 👇

📃 www.nature.com/articles/s41...
September 28, 2026 at 9:36 AM
Kendrick Resources posts high-grade REE intercepts at Teufelskuppe
Kendrick Resources posts high-grade REE intercepts at Teufelskuppe
Assays "have significantly exceeded expectations", the exploration company said
dlvr.it
September 28, 2026 at 9:25 AM
Yiqi Yao, Miquel Duran-Frigola: Interpretable-by-Design Descriptor Portfolios Match a 2048-Dimensional Foundation Embedding on Low-Data Molecular Assays https://arxiv.org/abs/2609.30789 https://arxiv.org/pdf/2609.30789 https://arxiv.org/html/2609.30789
September 28, 2026 at 6:43 AM
How Should Drug Teams Validate AI-Powered Assays Before Making Decisions? — https://aidrugsearch.com/knowledge/how_should_drug_teams_validate_ai-powered_assays_before_making_decisions.php
September 28, 2026 at 5:23 AM